Reply to Li and Colleagues
Overview
Overview
Journal
J Natl Cancer Inst
Publisher
Oxford University Press
Specialty
Oncology
Date
2023 Apr 2
PMID
37004196
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Li S, Nguyen-Dumont T, Southey M, Hopper J
. RE: Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer. J Natl Cancer Inst. 2023; 115(6):757-759.
PMC: 10248828.
DOI: 10.1093/jnci/djad056.
View
2.
Li H, Sisoudiya S, Martin-Giacalone B, Khayat M, Dugan-Perez S, Marquez-Do D
. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Natl Cancer Inst. 2020; 113(7):875-883.
PMC: 8246828.
DOI: 10.1093/jnci/djaa204.
View
3.
McGee R, Oak N, Harrison L, Xu K, Nuccio R, Blake A
. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management. Clin Cancer Res. 2023; 29(7):1243-1251.
PMC: 10642481.
DOI: 10.1158/1078-0432.CCR-22-2482.
View
4.
Gillani R, Camp S, Han S, Jones J, Chu H, OBrien S
. Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. Am J Hum Genet. 2022; 109(6):1026-1037.
PMC: 9247831.
DOI: 10.1016/j.ajhg.2022.04.007.
View
5.
Waszak S, Northcott P, Buchhalter I, Robinson G, Sutter C, Groebner S
. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018; 19(6):785-798.
PMC: 5984248.
DOI: 10.1016/S1470-2045(18)30242-0.
View